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Immunoglobulin synthesis by peripheral blood mononuclear cells in
minimal change nephrotic syndrome. The spontaneous and pokeweed
mitogen (PWM)-induced immunoglobulin synthesizing activities of cir-
culating mononuclear cells (MNC) from minimal change nephrotic
syndrome systemic (MCNS) patients in relapse (N = 13) were com-
pared with those of patients in remission (N = 9), patients with active
systemic lupus erythematosus (SLE, N 9), and healthy controls (N =
17). Cumulative amounts of 1gM, IgU, and IgA secreted over a 12-day
culture period were determined in a solid phase radioimmunoassay.
Mean levels of spontaneous immunoglobulin production in control
cultures did not exceed 370 ng/ml. In contrast unstimulated 1gM, IgG,
and IgA synthesis among MCNS patients in relapse averaged 588, 1258,
and 2665 nglml, respectively. The majority of patients exhibited syn-
thetic activities that equalled or exceeded those of patients with active
SLE. Spontaneous immunoglobulin production declined by 80 to 97%
in three patients restudied in stable remission. A fourth patient with
frequent relapses maintained high rates of synthesis in remission as well
as in relapse. PWM stimulation increased immunoglobulin production
in patients in remission and controls but failed to increase or suppressed
immunoglobulin secretion in SLE patients and patients in relapse.
These results suggest that MNC from MCNS patients in relapse are
reversibly activated in vivo.
Synthêse d'immunoglobulines par des cellules mononucléaires du sang
péripherique dans le syndrome néphrotique a lesions minimes. Les
activités de synthese d'immunoglobulines spontanées et induites par le
mitogen pokeweed (PWM) des cellules mononucléaires (MNC) circu-
lants provenant de malades ayant une syndrome nëphrotique a lesions
minimes (MCNS) en rechute (N = 13) ont été comparées avec celles de
malades en remission (N = 9), de malades ayant un lupus erythemateux
aigue disséminé (SLE) actif (N = 9), et de contrôles sains (N = 17). Les
quantités cumulatives d'IgM, d'IgG, et d'IgA sécrétées pendant une
periode de culture de l2jours ont été déterminCes par un radioimmun-
oessai en phase solide. Les concentrations moyennes de production
spontanée d'immunoglobulines dans les cultures contrôles ne dépas-
saient pas 370 ng/ml. Par contraste, Ia synthese non stimulée d'lgM,
d'IgG, et IgA parmi les malades ayant une MCNS en rechute était en
moyenne de 588, 1258, et 2665 ng/ml, respectivement. La majoritC des
malades avait des activités synthétiques qui egalaient ou excédaient
celles de malades ayant un SLE actif. La production spontaneé
d'immunoglobulines s'est abaissée de 80 a 97% chez trois malades
réétudiés lors dune remission stable. Un quatrième malade avec des
rechutes frequentes a conserve des taux elevés de synthèse en rémis-
sion comme en rechute. La stimulation par le PWM a augmenté Ia
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production d'immunoglobulines chez les malades en remission et chez
les contrOles, mais n'a pas augmenté ou a supprimée Ia sécrétion
d'immunoglobulines chez les malades avec on SLE et chez les malades
en rechute. Ces résultats suggèrent que les MNC provenant de malades
avec MCNS en rechute sont réversiblement activCs in vivo.
Minimal change nephrotic syndrome (MCNS) is presently
viewed by many physicians as an immunologic disorder. The
evidence for this is indirect and includes such diverse consider-
ations as the unexplained sensitivity of the disease to steroids
and other immunosuppressive agents [1, 2], its highly signifi-
cant association with HLA DRw7 [3, 41, its dramatic reversal
following measles [5] and malaria [61 infections, and its seasonal
occurrence in certain atopic individuals [71. Since neither
immunoglobulin nor complement deposition are common fea-
tures of the disease, the precise manner in which the immune
system mediates changes in protein permeability within the
kidney remains open to speculation. In 1968 Levinsky et al [81
demonstrated circulating immune complexes in the sera of
children with MCNS, a finding subsequently confirmed by
Phillips et al [91, also in children, and by Cairns, London, and
Mallick, [101 and by the collaborative study of adult idiopathic
nephrotic syndrome [111 in adults. Although the pathogenic
importance of immune complexes in MCNS is unclear, their
undeniable presence must be regarded as a reflection of altered
immune activity. To evaluate the humoral status of children
with MCNS, we measured the cumulative amounts of immuno-
globulin synthesized and secreted by their peripheral blood
mononuclear cells during a 12-day culture period. The results
indicate that in patients in relapse spontaneous IgA, IgG, and
1gM production are increased markedly, moderately, and mild-
ly, respectively, when compared to values obtained in patients
in remission and healthy controls.
Methods
Patients. Nineteen children (8 girls and 11 boys) with MCNS
were studied (Tables I and 2). Each responded to prednisone on
one or more occasions. Renal biopsy specimens obtained from
17 patients demonstrated minimal glomerular pathology. In two
children (patients numbered 7 and 14) the diagnosis was made
clinically. Group I consisted of 13 patients (7 girls and 6 boys;
age range, 2 to 17 years) in relapse as evidenced by heavy
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Table 1. Clinical and laboratory data of group 1 minimal change nephrotic syndrome patients
Serum Serum
Patient Age Recent albumina cholesterola
no. years Sex URI Proteinuria gidi mg/dl
Period off
prednisone
1 2 F — 3+ 1.6 658 1st episode
2 9 F + 3+ 1.9 396 1st episode
3 2 M + 3+ 1.3 521 1st episode
4 16 F — 3+ 1.9 442 7 years
5 9 M — 3+ — — Smonths
6 4 F — 3+ 1.3 369 1st episode
7 8 M + 3+ 1.7 463 3 months
8 9 F + 3+ 1.3 313 1 week
9 11 M + 3+ 1.8 312 18 months
10 17 M + 3+ 1.1 461 3 months
11 5 M — 2+ 2.4 326 Smgon
alternate days
12 10 F + 3+ 3.1 157 3 years
13 17 F + 3+ 1.6 456 2 years
Normal range for serum albumin and cholesterol (mean 2 SD) = 3.2 to 5.0 g/dl and 130 to 250 mg/dl, respectively.
Table 2. Clinical and laboratory data of group 2 minimal change nephrotic syndrome patients
Serum Serum
Patient Age Recent albumin cholesterol Period off Duration of
no. years Sex URI Proteinuria gidi mg/dl prednisone remission
3 4 M — — 3.7 221 5 months 1 year
4 16 F — — 4.5 191 4 months 7 months
13 17 F — — — — 2 weeks 4 months
14 4 F — — 4.0 250 1 month 4 months
15 7 M — — — — 17 months 21 months
16 17 M — — 4.4 162 5 months 11 months
17 19 M — — 4.2 184 4 months 8 months
18 14 M — — 4.2 197 7 months 11 months
19 13 M — — — — 1 month 4 months
proteinuria (Table 1). Four children were experiencing their
first episode and had not been treated. One patient was taking 5
mg of prednisone on alternate days and another had been
tapered off prednisone 1 week earlier. The remaining seven
patients had not received prednisone for a period of 3 months to
7 years. Serum 1gM, IgG, and IgA concentrations for the group
averaged 237.0 1.11 (mean SEM), 39.8 1.15, and 96.4
1.08% of the normal geometric means for age, respectively.
Although no patient exhibited signs of active infection at the
time of study, several reported recent upper respiratory
infections.
Group 2 was composed of nine children (3 girls and 6 boys;
age range, 4 to 19 years) in remission (Table 2). The patients
were free of proteinuria for 4 to 21 months and off all medication
for 2 weeks to 17 months. Their mean serum 1gM, IgG, and IgA
concentrations were 209 1.22, 88.7 1.13, and 96.1 1.10% of
the age-established geometric means, respectively. Patients 3,
4, and 13 had initially been studied while in relapse. Patient 19
was evaluated on several occasions both while in relapse and
following remission and is presented in greater detail in the
Results section.
None of the patients had been transfused recently. One
patient studied only in relapse (patient 12), another studied
exclusively in remission (patient 16), and two patients studied
during relapse and remission (patients 4 and 13) had received
cytoxan for 3 to 9 months 5 to 8 years previously.
Nine patients (7 girls and 2 boys; age range, 10 to 21 years)
with active systemic lupus erythematosus (SLE) were also
evaluated. The clinical features and lymphocyte studies in eight
of these patients have been described previously [12]. The ninth
patient presented with fever, rash, arthralgias, and circulating
antibody to double stranded DNA. She was discovered to have
a selective IgA deficiency after her cells failed to synthesize IgA
in vitro. Four patients were untreated; five were receiving
prednisone in dosages ranging from 5 mg every other day to
17.5 mg daily. One patient had nephrotic syndrome (serum
albumin 2.5 gIdl, cholesterol 439 mg/dl). The patients' serum
1gM, IgG, and IgA concentrations averaged 170.0 1.27, 170.1
1.10, and 107.4 1.36% of the normal geometric means for
age, respectively.
The control group consisted of 17 healthy volunteers (8
females and 9 males; age range, 21 to 37 years).
Cell separation. Mononuclear cells (MNC) were isolated
from the peripheral blood (10 to 30 ml) of normal volunteers and
patients with MCNS and SLE by Ficoll-Hypaque centrifugation
[13]. Cells recovered at the interface were subjected to exten-
sive washing to remove cytophilic immunoglobulin including
two washes in Hanks balanced salt solution (HBSS; Microbio-
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Fig. 1. Geometric mean (± SCM) basal and
PWM-induced immunoglobulin (Ig) production
rates of unfractionated MNC from healthy
controls, MCNS patients in relapse and
remission, and patients wtih active SLE. The
number of individuals studied is shown in
parentheses.
Fig. 2. Results of individual determinations of
spontaneous Ig synthetic rates in patients with
MCNS and SLE from 12-day cultures. Shaded
areas represent the geometric mean SEM for
spontaneous immunoglobulin production rates
in 17 control experiments.
logical Associates, Bethesda, Maryland) containing 2.5 mM
EDTA, three washes in HBSS with 5% heat-inactivated fetal
calf serum (FCS), and three washes through 100% FCS. On two
occasions MNC from an MCNS patient (patient 19) and a
healthy control were separated into enriched populations of T
and B cells using an overnight E rosette technique as previously
described [12, 14]. The washed MNC (20 >< 106/ml) were
combined with an equal volume of a freshly prepared 5% sheep
erythrocyte (Colorado Serum Co., Denver, Colorado) mixture
in RPM! 1640 (GIBCO, Grand Island, New York) with 10%
FCS. The cells were centrifuged at x5Og for 5 mm (4°C) and
incubated overnight at 4°C. Rosetting T cells were separated
from nonrosetting B cells by resuspending the pellet over
Ficoll-Hypaque and centrifuging at X400g for 40 mm. B cells
layering at the interface were washed three times in RPMI 1640
with 10% FCS. The final populations contained less than 5% E
rosetting cells and greater than 75% surface immunoglobulin
bearing cells. T cells were released from the pellet by rapid
distilled water lysis and washed three times in RPMI 1640 with
10% FCS. The final T cell preparations contained greater than
75% E-rosetting cells, less than 3% surface immunoglobulin
bearing cells, and failed to respond to pokeweed mitogen
(PWM; GIBCO, Grand Island, New York) stimulation in the
immunoglobulin synthesis assay.
Culture conditions. Cells prepared as above were cultured in
the presence and absence of PWM (10 .d/ml) in RPMI 1640
media supplemented with 2 mrvi L-glutamine, 50 g/ml penicil-
lin, 50 g/ml streptomycin, 5 pg/mI gentamycin, and 10% heat-
inactivated FCS. Cultures were performed in triplicate in
flatbottomed microtiter plates at a final volume of 0.2 ml.
Unfractionated MNC were cultured at concentrations of 2 x
106/ml. In co-culture experiments between B cells and autolo-
gous and allogeneic T cells, the B and T cell populations were
maintained at 2 x l06/ml and 4 x 106/ml, respectively. Cultures
were incubated at 37°C in a 5% CO2 humidified atmosphere for
12 days. The length of the incubation period was derived from
preliminary studies showing that the amount of immunoglobulin
secreted by normal lymphocytes reached a maximal level on
day 12 of the culture. Supernatants were harvested and stored
at —70°C until the immunoglobulin content could be analyzed.
Radioimmunoassay. The cumulative amounts of 1gM, IgG,
and IgA produced during the 12-day culture period were
determined by a solid phase radioimmunoassay performed in
round-bottomed microtiter plates as previously described [12,
15]. Briefly, 10 a1 of supernatant or standard were combined
with 50 pJ of radiolabeled (1251) human 1gM, IgG, or IgA and 50
1uJ of a commercially obtained immunobead preparation (Bio-
Rad Laboratories, Richmond, California) which consists of
isotype specific rabbit anti-human immunoglobulin covalently
linked to polyacrylamide beads. Following an overnight incuba-
tion at 25°C, the wells were harvested onto glass fiber filter
strips using a Beilco microharvester (Bellco, Vineland, New
Jersey). Precipitates were counted in a Gamma 4000 gamma
counter (Beckman, Palo Alto, California). The amounts of 1gM,
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IgG, and IgA in the experimental supernatants were derived
from linear regression analysis of the points on the standard
curves. To test for the effective removal of nonspecifically
bound immunoglobulin prior to placing the cells in culture, the
immunoglobulin concentrations in supernatants of cells which
had been frozen and thawed three times or which had been
harvested after 30 mm of incubation were measured. The values
did not exceed 200 ng/ml.
Statistical methods. The average 1gM, IgG, and IgA produc-
tion for each group of subjects are expressed as geometric
means. Comparisons between groups are based on Student's
test.
Results
In vitro immunoglobulin synthesis. Figure 1 compares the
spontaneously and PWM-induced immunoglobulin synthetic
rates of MCNS patients in relapse (group 1) with those of
MCNS patients in remission (group 2), patients with active
SLE, and healthy controls. In normal subjects basal rates of
1gM, IgG, and IgA production averaged 145 1.28, 189 1.23,
and 363 1.25 ng/ml, respectively. Following PWM stimulation
1gM synthesis rose tenfold (1515 1.85 ng/ml), IgG synthesis
eightfold (1564 1.58 ng/ml), and IgA synthesis threefold
(1216 1.52 nglml). Patients with MCNS in relapse exhibited
markedly elevated levels of spontaneous immunoglobulin syn-
thesis. Their mean 1gM production (588 1.31 ng/ml) was four
times normal, their mean IgG production (1258 1.54 ng/ml) six
times normal and their mean IgA production (2665 1.34 ng/ml)
seven times normal. Moreover, several patients demonstrated
synthetic rates which were as great or greater than those
observed in patients with active SLE (Fig. 2). IgA was the
major immunoglobulin class effected with synthesis of this
isotype exceeding that of both IgG and 1gM in nine of the 13
MCNS patients evaluated. In the SLE population 1gM, IgG,
and IgA synthesis averaged 1145 1.66, 4390 1.46, and 4427
1.21 ng/ml, respectively. Of the nine SLE patients studied, five
synthesized more IgG than IgA and four more IgA than IgG.
Although 1gM synthesis exceeded the normal range both in the
children with MCNS and in the patients with SLE (Fig. 2), the
cumulative amount of 1gM produced by a given patient's cells
was lower than that of either IgG or IgA in all 13 MCNS patients
and in eight of nine SLE patients.
The addition of PWM failed to further enhance the immuno-
globulin synthesizing activities of MCNS and SLE lymphocytes
(Fig. 1). In the MCNS patients in relapse mean rates of PWM
stimulated 1gM (893 1.51 ng/ml) and IgG (1602 1.42 ng!ml)
synthesis were not significantly different (P = 0.125) from their
mean spontaneous production rates. Moreover, IgA synthesis
(1807 1.42 ng/ml) was significantly lower (P < 0.003) in PWM
pulsed cultures than in cultures in which mitogen was not
present. Of the 13 patients evaluated, 1gM synthesis declined in
five (41 to 92%, mean 64%), IgG synthesis in six (26 to 86%,
mean 62%), and IgA synthesis in ten (11 to 80%, mean 51%).
PWM-induced suppression was even more pronounced in SLE
cultures where the presence of mitogen caused a reduction in
the synthesis of all three immunoglobulin classes in every
patient studied.
Patients with MCNS in remission exhibited significantly
lower (P < 0.001) rates of spontaneous 1gM (255 1.44 ng/ml),
IgG (344 1.33 ng/ml) and IgA (462 1.35 ng/ml) synthesis than
patients in relapse (Fig. I). The differences in synthetic activity
were particularly evident in patients 3, 4, and 13 whose cells
secreted less than one fifth of the amount of IgG and IgA that
they had produced during relapse. Patient 19, a child with
frequent relapses, maintained high levels of spontaneous
immunoglobulin synthesis in remission as well as in relapse. In
general PWM-induced suppression receded as basal synthetic
rates declined. Lectin stimulation caused a sixfold rise in 1gM
synthesis (1434 1.24 ng/ml), a fourfold rise in IgG synthesis
(1205 1.65 ng/ml), and a fourfold rise in IgA synthesis (1778
1.69 ng/ml). Three of the patients who exhibited normal synthe-
sizing patterns during remission suffered relapses 2 weeks
(patient 18), 5 months (patient 16), and 16 months (patient 4)
after having been studied.
Serial studies. The results of serial determinations of sponta-
neous and PWM-induced immunoglobulin synthesis in patients
4 and 19 are presented in Figures 3 and 4. Patient 4 was a 17-
year-old female who was initially studied while experiencing
her first relapse since receiving cytoxan 6 years earlier. Al-
though the data shown in Figure 3 pertains to 1gM synthesis, the
results for IgG and IgA were comparable. During a time when
the patient was in relapse but untreated, her peripheral blood
MNC spontaneously synthesized increased amounts of
immunoglobulin which were depressed by PWM stimulation.
When restudied after being in remission for 3 months and off
prednisone for 2 weeks, the spontaneous immunoglobulin pro-
duction had declined by more than 50%, but PWM stimulation
failed to generate a normal enhancement pattern. Also, al-
though the patient's serum IgG had risen from 361 to 595 mg/dl
and her serum 1gM had fallen from 400 to 290 mg/dl, the
concentrations of both immunoglobulins remained outside the
age-established normal ranges. Four months later, while still in
remission, the patient was studied a second time. On this
occasion PWM stimulation caused a brisk rise in the synthesis
of all three immunoglobulin classes. Moreover, the patient's
serum IgG (240 mg/dl) and 1gM (215 mg/dl) levels had returned
to normal. The patient stayed in remission for a total of 24
months, eventually relapsing during the second trimester of her
first pregnancy.
Patient 19 was a 13-year-old male who had had numerous
relapses since the onset of his illness at age 6 years. He was first
evaluated when he had been in remission for 3 months and was
still receiving prednisone 5 mg every other day (Fig. 4).
Spontaneous IgA production was increased markedly (8495 ng/
ml), declining in the presence of PWM (3338 ng/ml). When he
was restudied in relapse 10 months later and again in remission
15 months later, similar patterns of high spontaneous IgA
production and impaired PWM responsiveness were observed.
To assess the influence of high-dose steroids on the immuno-
globulin synthesizing activity of the patient's cells and to
document qualitative and/or quantitative changes in immuno-
globulin secretion coincident to clinical improvement, we re-
evaluated the patient in relapse 3 days after his prednisone had
been raised to 100 mg daily and again 6 days later when he had
begun to diurese. His spontaneous IgA synthesis (16,486 ng/mI)
was considerably higher when he was receiving 100 mg of predni-
sone a day than it was 4 days earlier (9418 ng/ml) when his
dosage had been 60 mg every other day (data not shown) and 13
months earlier (1196 ng/ml) when he had not received treatment
for several months. Moreover, although spontaneous IgA syn-
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Fig. 3. Sequential studies of spontaneous (open columns) and PWM-
induced (closed columns) 1gM synthesis in a 17-year-old MCNS patient
(no. 4). The results for IgG and IgA synthesis were qualitatively similar
to those shown for 1gM. Values represent the mean of quadruplicate
determinations for each experiment. The shaded area indicates the
mean SEM for spontaneous 1gM synthesis in 17 healthy controls.
thesis was lower (5238 nglml) at the time of diuresis than in full
relapse it was still very high, far exceeding the mean level of
IgA produced in PWM-stimulated control cultures (1216 nglml).
Thus, neither the administration of high-dose steroids nor the
onset of remission appeared to be associated with correction of
the heightened synthetic activity of the patient's MNC. Al-
though elevations in IgA synthesis consistently exceeded those
of IgG and 1gM, changes in the production of these isotypes
paralleled those of IgA throughout the period of investigation.
Co-culture experiments. A series of co-culture experiments
were undertaken between the patient just described (Fig. 4) and
a healthy control to examine selectively alterations in patient B
and T cell function. Studies were initially conducted while the
patient was in relapse receiving 100 mg of prednisone a day and
repeated 6 days later when the patient had begun to diurese,
utilizing the same control subject on both occasions. Several
differences between control and patient cell performance were
observed (Fig. 5). In relapse the patient's B cells maintained a
high level (3153 nglml) of spontaneous IgA production (as well
as IgG and 1gM) relative to control (308 ng/ml) despite prior T
cell depletion. This synthetic activity was inhibited partially by
the addition of PWM and by normal allogeneic T cells but not
by autologous T cells. When control B cells were co-cultured
with patient T cells or autologous T cells in the presence of
PWM, IgA production rose three- to fivefold. In contrast, when
co-cultures between patient B cells and autologous or allogene-
ic T cells were stimulated with PWM, IgA synthesis either
declined or failed to increase. Similar disturbances were noted
when identical studies were performed while the patient was
undergoing a diuresis (Fig. 5).
Discussion
Hypogammaglobulinemia has been recognized as a feature of
nephrotic syndrome for several decades. Metabolic studies
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Fig. 4. Sequential studies of spontaneous (open columns) and PWM-
induced (closed columns) IgA synthesis in a 13 year-old MCNS patient
(no. 19) with a frequently relapsing course. Values represent the mean
of quadruplicate determinations for each experiment. The shaded area
indicates the mean SEM for spontaneous IgA production in 17 healthy
controls.
performed in the 1950s and '60s implicated both an increase in
catabolism as well as an increase in urinary loss as the major
factors responsible for the serum deficit [16, 17]. In 1972
Waldman, Strober, and Mogielnicki showed that while the
survival of IgG molecules was decreased markedly, 1gM metab-
olism remained essentially normal [18]. Reports have differed
with respect to immunoglobulin synthesis which has been
variably described as both normal [16] and increased [17]. In
this study we evaluated the immunoglobulin synthesizing activi-
ty of peripheral blood MNC from children with MCNS using an
in vitro culture system. Results show that in relapse the
patients' cells synthesize large amounts of immunoglobulin in
the absence of mitogen suggesting that the cells have undergone
stimulation in vivo. That the increase represents a primary
event rather than a compensatory response to accelerated
metabolism is supported by the fact that IgA and 1gM produc-
tion are increased in addition to IgG at a time when serum IgA
and 1gM concentrations are either normal or elevated. Signifi-
cantly lower levels of synthesis were observed among the
majority of MCNS patients in remission indicating that in-
creased immunoglobulin secretion was a transient phenome-
non. Moreover, the synthetic patterns of patients in remission
approached those of healthy adults who were studied in lieu of
available pediatric controls.
The conditions leading to increased immunoglobulin produc-
tion during relapse are unclear. Many of the patients had had
recent upper respiratory infections but several denied any
antecedent illness yet exhibited synthetic patterns that were
indistinguishable from those of patients who had been ill.
Changes in the numbers of circulating B cells, suppressor T
cells, or helper T cells could result theoretically in augmented
synthesis. However, these parameters have been examined in a
number of MCNS patients by a variety of techniques and to
date no major disturbances have been uncovered [19—21]. The
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Fig. 5. Results of co-culture studies from a normal subject and a 13-
year-old MCNS patient (no. 19) with B cells cultured alone and with
autologous and allogeneic T cells in the presence and absence of PWM.
The upper half of the figure shows the outcome of co-culture experi-
ments performed when the patient was in relapse and receiving predni-
sone 100 mg/day. The lower half of the figure shows the results of
identical experiments performed 6 days later when the patient was
diuresing and still receiving prednisone 100 mg/day. The same control
individual was used on both occasions. Values represent the mean of
quadruplicate determinations for each experiment.
outcome of co-culture studies utilizing enriched B and T cell
populations from an MCNS patient in relapse suggest that both
an increase in B cell activity and a reduction in T cell regulation
contribute to the high rate of spontaneous secretion. The fact
that enhanced levels of synthesis were documented occasional-
ly either at the time of diuresis or following remission suggests
that events separate from or in addition to enhanced immuno-
globulin production underlie the fluctuations in glomerular
permeability characteristic of minimal change disease.
Because IgA is regarded principally as a secretory protein, its
emergence as the major immunoglobulin produced by circulat-
ing lymphocytes from MCNS patients in relapse is particularly
unexpected. There is considerable evidence from animal stud-
ies that cells stimulated by antigen in a mucosal area migrate
through the lymphatics into the circulation and ultimately home
to mucosal surfaces and exocrine glands throughout the body
[22, 23]. In this manner the entire organism is afforded protec-
tion against an antigen presented at a single site. Although the
majority of cells are committed to IgA synthesis, some lgG and
1gM producing cells participate as well [23]. Recently Yarchoan
et al presented data which support the existence of a similar
redistribution process in man [241. These investigators isolated
IgG and IgA anti-influenza virus antibody from the superna-
tants of unstimulated MNC obtained from the circulation of
individuals inoculated intranasally with cold-adapted influenza
virus. The same phenomenon may apply to MCNS patients in
relapse. More specifically, the spontaneously synthesizing cells
in their peripheral blood may represent cells in transit from a
site of antigenic stimulation such as the respiratory tract to a
distant mucosal location. Alternatively the cells may have
arisen from the bone marrow, the richest source of IgA secret-
ing cells in man [25] or from another central lymphoid organ.
Whatever their origin, their presence in the circulation raises
additional questions such as whether or not excessive amounts
of antibody are being produced and whether or not the period of
activation is abnormally prolonged which are equally relevant
and will require further investigation to answer.
In several MCNS patients in relapse, PWM stimulation
caused a decline in immunoglobulin secretion. This seemingly
paradoxical response had been previously observed by us in
patients with Henoch-Schonlein purpura [12] and by ourselves
and others in patients with SLE [12, 26—29]. The degree of
depression appears to correspond to the level of immunoglob-
ulin produced in unstimulated cultures. Although the mecha-
nism of suppression has not been rigorously defined, several
possibilities exist. Broder et al demonstrated that PWM has the
capacity to activate precursors of suppressor T cells to become
suppressor-effector cells in the presence of an inducer T cell
population [30]. Thus, comparatively low levels of immuno-
globulin synthesis in PWM-stimulated cultures could result
from a relative or absolute increase in pro-suppressor T cells. In
separate experiments Stevens et al have shown that PWM
inhibits the release of antitetanus toxoid antibody from unstim-
ulated B cells of individuals recently immunized with tetanus
toxoid [31]. A direct influence on B cell kinetics has been
postulated. Finally lymphoblastoid B cells have been shown to
have the capacity to selectively activate autologous T cells
which are in turn capable of suppressing PWM-stimulated
immunoglobulin synthesis [32]. These events are not mutually
exclusive and may contribute singly or in combination to the
PWM-related suppression in MCNS cultures.
One might ask why, if patients with MCNS and SLE express
similar features of polyclonal activation, do they then manifest
such vastly different symptomatology? The answer may reside
in the nature of the antibody being produced. During periods of
clinical activity SLE patients exhibit high levels of antibody
formation against chemical [33], viral [34], and autologous [35]
antigens. In contrast the specificity of the antibody secreted by
MCNS cells is largely unknown. However, recently Phillips et
al described anti-smooth muscle and anti-kidney tubular antigen
activity in the sera and circulating immune complexes of
patients with MCNS [9]. Further characterization of the anti-
body released in unstimulated MCNS cultures may provide new
insight into the underlying etiology of this puzzling disorder.
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